Phase II Open-Label Study of Taxoprexin (DHA-paclitaxel) Injection by 2-Hour Intravenous Infusion in Patients with Metastatic, Locally Advanced or Unrespectable Renal Cell Carcinoma

  • DOUKAS, MICHAEL (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date2/1/029/30/02